drugset / Trial / NCT06534255
A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.
NaSingle-groupOpen-labelTreatment
Summary
A study to evaluate the safety, efficacy, and pharmacokinetics of MegaLT in treating refractory thrombocytopenia following radiotherapy, chemotherapy, or transplantation.
Timeline
- Start
- 2024-12-04
- Primary completion
- 2025-06-19
- Completion
- 2026-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MegaLT injection | Unknown | 1e+06 cells/kg | Intravenous |
| Subject | MegaLT injection | Unknown | 5e+06 cells/kg | Intravenous |
| Subject | MegaLT injection | Unknown | 1e+07 cells/kg | Intravenous |